Sign In
Buy CRON
$2.71
-0.0200 (-0.733%)
At Close: Jun 03, 2026
3 Canadian Marijuana Stocks That Could Help You Make Money
11:35am, Wednesday, 03'rd Jun 2026
Those who have been investing in marijuana stocks over the years have seen many changes. If you have been investing and trading since just before the pandemic, then you know how exciting the sector ca
Top Canadian Marijuana Stock Choices For Better Investing In 2026
10:53am, Friday, 22'nd May 2026
Many marijuana stock investors have a strong positive outlook on the future of the market. If you've been watching the cannabis sector, then you know how volatile and uncertain trading can be. Yet the
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
10:03pm, Thursday, 14'th May 2026
Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in th
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)
11:39am, Wednesday, 13'th May 2026
Cronos Group Inc. reported Q1 '26 revenue up 40% to $45 million, exceeding estimates. Despite strong top-line growth, CRON posted a small operating loss of $1.8 million, with net income driven by inte
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
08:50pm, Monday, 11'th May 2026
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Cronos Group Q1 Earnings Call Highlights
10:09am, Monday, 11'th May 2026
Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued internation
Cronos Group (CRON) Q1 Earnings Meet Estimates
09:45am, Monday, 11'th May 2026
Cronos Group (CRON) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago.
Cronos Group Reports 2026 First Quarter Results
07:30am, Monday, 11'th May 2026
Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
07:30am, Wednesday, 06'th May 2026
TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
07:30am, Wednesday, 29'th Apr 2026
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 18, 202
Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison
01:12am, Monday, 27'th Apr 2026
Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and Cronos Group (NASDAQ: CRON - Get Free Report) are both medical companies, but which is the better investment? We will compare the two compa
Incannex Healthcare (NASDAQ:IXHL) and Cronos Group (NASDAQ:CRON) Financial Contrast
02:30am, Saturday, 25'th Apr 2026
Cronos Group (NASDAQ: CRON - Get Free Report) and Incannex Healthcare (NASDAQ: IXHL - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
07:30am, Monday, 20'th Apr 2026
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
12:40pm, Wednesday, 15'th Apr 2026
Marijuana stock investors are still in a position where volatility and speculation control the outcome. Especially with all the laws and regulatory changes that have transformed the cannabis industry.
Financial Comparison: Cronos Group (NASDAQ:CRON) & Kiora Pharmaceuticals (NASDAQ:KPRX)
01:09am, Tuesday, 14'th Apr 2026
Cronos Group (NASDAQ: CRON - Get Free Report) and Kiora Pharmaceuticals (NASDAQ: KPRX - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the
